Analysis of the efficacy, safety, and regulatory status of novel forms of creatine - Test2 - elhamkhani - TriplyDB

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

http://www.wikidata.org/entity/Q24610725

about

A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate Creatine supplementation with specific view to exercise/sports performance: an update Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.How the use of creatine supplements can elevate serum creatinine in the absence of underlying kidney pathology.Modifications of the 1H NMR metabolite profile of processed mullet (Mugil cephalus) roes under different storage conditions.Effects of dietary creatine supplementation on systemic microvascular density and reactivity in healthy young adults Protein and amino acid supplementation in older humans.Creatine supplementation and aging musculoskeletal health.Effects of short-term ingestion of Russian Tarragon prior to creatine monohydrate supplementation on whole body and muscle creatine retention and anaerobic sprint capacity: a preliminary investigation.Selected In-Season Nutritional Strategies to Enhance Recovery for Team Sport Athletes: A Practical Overview Fenugreek increases insulin-stimulated creatine content in L6C11 muscle myotubes.Creatine and creatine forms intended for sports nutrition.Creatine: Polymorphs Predicted and Found.Hematological and Hemodynamic Responses to Acute and Short-Term Creatine Nitrate Supplementation.Protection Before Impact: the Potential Neuroprotective Role of Nutritional Supplementation in Sports-Related Head Trauma.In memory of Professor Eric Helmer Hultman.Plasma Creatine Kinetics After Ingestion of Microencapsulated Creatine Monohydrate with Enhanced Stability in Aqueous Solutions.Adverse effects of sports supplements in men.Stability of creatine derivatives during simulated digestion in an in vitro model.Creatine Effects of Fear Appeals on Communicating Potential Health Risks of Unregulated Dietary Supplements to College Students

P2860

Q21245413-EEA148D3-6A7B-45B4-95DC-A6ECC95506C0 Q24628688-2851A2DB-18BD-4857-8D11-AF4FB3369260 Q27006952-33FD5218-A05E-434B-B383-4070447D2387 Q33791877-4CDED88F-63DA-4CF5-98B0-3F935C5E9B9D Q34177044-F80773F2-F805-43DB-A584-0A290CDA958F Q34221216-171F52B4-1A95-4EBC-9558-AF387E4F89CF Q34243177-D7E637D9-3A6D-425D-9A96-10307FA9671D Q34778540-8C71F6A4-4008-44C9-B625-C7F59C280166 Q38096904-D3EB224F-9E97-4452-ACD2-60EFB7355341 Q38159939-73F79024-7439-4950-A5F8-B4E7CEB579C6 Q38617923-4909B14B-DC3B-4136-BF6D-647ECB60A033 Q38658380-B1B60AF3-0E62-48D7-BCCE-2EC269231346 Q38806389-C0FD5C9D-BBA4-4A4C-AA8C-97F62B093C43 Q39055380-AEA9ED5D-F28D-48F4-854D-2CEBE51E4D81 Q40153406-12303BFC-AEA8-4DEC-BDA8-4FEDA5EF44D2 Q47303674-3CC35BA9-AAB4-4B06-A645-8FC14B91BB0B Q47840928-A70EF2C7-A9D4-4A2B-9C7E-93873C3BA3A2 Q48444137-B15C59DC-956C-4756-A69E-66EFCF0DF631 Q51169569-E00C041E-6495-44FD-98DC-D69574EAB78B Q52673112-4CF3AB25-5517-400D-A143-C2B73EFCC48E Q52881144-7B44781E-8E55-4E62-8C65-0E63B9E889F6 Q57915272-7AF1192B-0FB3-432E-91E2-CCF30FE0D436 Q58176891-39873EAE-BE9C-43A8-93DA-ECAC024E1EFB

P2860

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

http://www.wikidata.org/entity/Q24610725

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@ast

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@en

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@nl

type

label

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@ast

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@en

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@nl

prefLabel

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@ast

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@en

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@nl

P1433

Q24610725-423B7287-4C79-4E1B-B186-8D24E7055326

P1476

Q24610725-714CC497-DD49-4195-B751-0F30C4F544AF

P2093

Q24610725-024304BD-F59E-4EC8-9C19-587438DB5DEE

Q24610725-49B70BE8-78F4-422E-A8E0-1B12D6709FCF

Q24610725-76CF37C9-77FD-4656-9023-0AA0FEE251B9

Q24610725-8881DF76-5C4E-4B0F-A4B5-98EF3FDBDEF2

Q24610725-E119641F-2AD7-42BF-B30B-469C60E3C296

P2860

Q24610725-0558959F-DDAB-463C-BC2C-5B5806761237

Q24610725-1896E301-2C29-408F-8DBF-F3758CB3B046

Q24610725-218E65CB-71E4-4E09-A388-67BB762B4329

Q24610725-2A625EE3-0F76-4B45-A556-629DED105014

Q24610725-2EC45439-85EC-47E1-A9CF-D3613A5F2863

Q24610725-34C302D3-8637-4B47-B250-3DFF710BF913

Q24610725-43B6D650-7E45-43D0-B130-03056C0145C2

Q24610725-48469E04-726E-474D-BAE9-4F8D46C0EF6D

Q24610725-51B9E3A3-E533-44DD-850C-11CB8B935136

Q24610725-5754CC58-3FC8-4524-8B8C-BEF2C5272E5B

P2888

Q24610725-10345A66-58A2-4162-AC3C-55AFF742E2D6

P304

Q24610725-0F6CB894-9F5F-44D0-8652-8D08344644C1

P31

Q24610725-57E68045-BE74-4EF2-8990-7C89ABED841B

Q24610725-85111FFC-D0BE-4907-9AB8-E54560DB1749

P356

Q24610725-21202880-4FA8-478C-9D58-2FC77D137B41

P407

Q24610725-DCCACA69-FA5F-41C8-8B83-B3E00BF9A2EC

P433

Q24610725-7187E71E-5E1C-4CDB-AA54-4EED16FD449E

P478

Q24610725-68EB3EBD-75B6-4578-989B-EE2E9DBB4678

P577

Q24610725-4E69FFE0-BF93-428A-8D0A-ECAC938222AD

Q24610725-D2D45301-2B71-4B54-8294-96C2C33478EC

P5875

Q24610725-4EA88DAE-7820-4482-B5CD-34E99642FDB8

P6179

Q24610725-40FB5EA5-ABDE-4159-A14B-0D73DA0F0CFA

P698

Q24610725-0058D166-C064-494C-B15D-9F9D6D974CC2

P921

Q24610725-9DBAAF45-999B-4076-9469-093F22EB72BB

Q24610725-B411782A-F961-4D82-B288-775F90C53033

Q24610725-E3E2EC2A-FF93-48C7-9ED3-2C511DA65B04

P932

Q24610725-BD1E0DBF-D421-4262-A503-BB94BEBD3374

P356

S00726-011-0874-6

P1433

P1476

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

@en

P2093

Andrew Shao

http://www.w3.org/2001/XMLSchema#string

Martin Purpura

http://www.w3.org/2001/XMLSchema#string

Ralf Jäger

http://www.w3.org/2001/XMLSchema#string

Richard B Kreider

http://www.w3.org/2001/XMLSchema#string

Toshitada Inoue

http://www.w3.org/2001/XMLSchema#string

P2860

ISSN exercise & sport nutrition review: research & recommendations

The effects of creatine ethyl ester supplementation combined with heavy resistance training on body composition, muscle performance, and serum and muscle creatine levels

International Society of Sports Nutrition position stand: creatine supplementation and exercise

Effects of creatine loading on electromyographic fatigue threshold during cycle ergometry in college-aged women

Protein- and carbohydrate-induced augmentation of whole body creatine retention in humans

Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration

Long-term creatine supplementation does not significantly affect clinical markers of health in athletes

Kinetics of creatine ingested as a food ingredient

Non-enzymatic hydrolysis of creatine ethyl ester

Comparison of new forms of creatine in raising plasma creatine levels

P2888

s00726-011-0874-6

P304

1369-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00726-011-0874-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50598159

http://www.w3.org/2001/XMLSchema#string

P6179

1035710911

http://www.w3.org/2001/XMLSchema#string

P698

21424716

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

P932

3080578

http://www.w3.org/2001/XMLSchema#string